Preeclampsia: Recent insights

Hypertension

Volumn 46, Issue 6, 2005, Pages 1243-1249

  Roberts, James M ^a,b,c   Gammill, Hilary S ^b  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Endothelium; Hypertension, pregnancy; Oxidative stress; Preeclampsia

Indexed keywords

HUMAN; MATERNAL HYPERTENSION; PATHOPHYSIOLOGY; PLACENTA PERFUSION; PREECLAMPSIA; PREGNANCY COMPLICATION; PRIORITY JOURNAL; PROTEINURIA; SHORT SURVEY;

ENDOCRINOLOGY; FEMALE; HUMANS; MATERNAL-FETAL EXCHANGE; PLACENTA; PRE-ECLAMPSIA; PREGNANCY; REGIONAL BLOOD FLOW;

EID: 31944436638     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.0000188408.49896.c5     Document Type: Short Survey

References (88)

1. Tang LC, Kwok AC, Wong AY, Lee YY, Sun KO, So AP. Critical care in obstetrical patients: an eight-year review. Chin Med J. 1997;110:936-941.
2. Goldenberg RL, Rouse DJ. Prevention of premature birth. N Engl J Med. 1998;339:313-320.
3. Duley L. Maternal mortality associated with hypertensive disorders of pregnancy in Africa, Asia, Latin America and the Caribbean. Br J Obstet Gynaecol. 1992;99:547-553.
4. Gifford RW, August PA, Cunningham G, Green LA, Lindheimer MD, McNellis D, Roberts JM, Sibai BM, Taler SJ. Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Am J Obstet Gynecol. 2000;183:S1-S22.
5. Roberts JM, Pearson G, Cutler J, Lindheimer M. Summary of the NHLBI Working Group on Research on Hypertension During Pregnancy. Hypertension. 2003;41:437-445.
6. Page EW. The relation between hydatid moles, relative ischemia of the gravid uterus, and the placental origin of eclampsia. Am J Obstet Gynecol. 1939;37:291-293.
7. Kaar K, Jouppila P, Kuikka J, Luotola H, Toivanen J, Rekonen A. Intervillous blood flow in normal and complicated late pregnancy measured by means of an intravenous 133Xe method. Acta Obstet Gynecol Scand. 1980;59:7-10.
8. Papageorghiou AT, Yu CK, Cicero S, Bower S, Nicolaides KH. Second-trimester uterine artery Doppler screening in unselected populations: a review. J Matern Fetal Neonatal Med. 2002;12:78-88.
9. Khalil RA, Granger JP. Vascular mechanisms of increased arterial pressure in preeclampsia: lessons from animal models. Am J Physiol. 2002;283:R29-R45.
10. Starzyk KA, Pijnenborg R, Salafia CM. Decidual and vascular pathophysiology in pregnancy compromise. Semin Reprod Endocrinol. 1999;17:63-72.
11. Hung T-H, Skepper JN, Chamock-Jones DS, Burton GJ. Hypoxia-reoxygenation: a potent inducer of apoptotic changes in the human placenta and possible etiological factor in preeclampsia. Circ Res. 2002;90:1274-1281.
12. Rodesch F, Simon P, Donner C, Jauniaux E. Oxygen measurements in endometrial and trophoblastic tissues during early pregnancy. Obstet Gynecol. 1992;80:283-285.
13. Jauniaux E, Watson AL, Hempstock J, Bao Y-P, Skepper JN, Burton GJ. Onset of maternal arterial blood flow and placental oxidative stress: a possible factor in human early pregnancy failure. Am J Pathol. 2000;157:2111-2122.
14. Graham CH, Burton GJ. Oxygen and trophoblast behaviour - a workshop report. Placenta. 2004;25(suppl A):S90-S92.
15. Zhou Y, Genbacev O, Damsky CH, Fisher SJ. Oxygen regulates human cytotrophoblast differentiation and invasion: implications for endovascular invasion in normal pregnancy and in pre-eclampsia. J Reprod Immunol. 39:197-213, 1998.
16. Campbell S, Rowe J, Jackson CJ, Gallery EDM. Interaction of cocultured decidual endothelial cells and cytotrophoblasts in preeclampsia. Biol Reprod. 2004;71:244-252.
17. King A, Hiby SE, Verma S, Burrows T, Gardner L, Loke YW. Uterine NK cells and trophoblast HLA class I molecules. Am J Reprod Immunol. 1997;37:459-462.
18. King A, Hiby S, Gardner L, Joseph S, Bowen J, Verma S, Burrows T, Loke Y. Recognition of trophoblast HLA class I molecules by decidual NK cell receptors-a review. Placenta. 2000;21(suppl A):S81-S85.
19. Hiby SE, Walker JJ, O'Shaughnessy KM, Redman CWG, Carrington M, Trowsdale J, Moffett A. Combinations of maternal KIR and fetal HLA-C genes influence the risk of preeclampsia and reproductive success. J Exp Med. 2004;200:957-965.
20. Allaire AD, Ballenger KA, Wells SR, McMahon MJ, Lessey BA. Placental apoptosis in preeclampsia. Obstet Gynecol. 2000;96:271-276.
21. Knight M, Redman CW, Linton EA, Sargent IL. Shedding of syncytiotrophoblast microvilli into the maternal circulation in pre-eclamptic pregnancies. Br J Obstet Gynaecol. 1998;105:632-640.
22. Roberts JM, Lain KY. Recent insights into the pathogenesis of pre-eclampsia. Placenta. 2002;23:359-372.
23. McCartney CP. The acute hypertensive disorders of pregnancy, classified by renal histology. Gynaecologia. 1969;167:214-220.
24. Chesley LC. Vascular reactivity in normal and toxemic pregnancy. Clin Obstet Gynecol. 1966;9:871-881.
25. Delemarre FM, Steegers EA, van Dop PA, de Jong PA. Angiotensin sensitivity test revisited. Hypertens Pregnancy. 2000;19:289-298.
26. Felfernig-Boehm D, Salat A, Vogl SE, Murabito M, Felfernig M, Schmidt D, Mittlboeck M, Husslein P, Mueller MR. Early detection of pre-eclampsia by determination of platelet aggregability. Thromb Res. 2000;98:139-146.
27. Ashworth JR, Baker PN, Warren AY, Johnson IR. Mechanisms of endothelium-dependent relaxation in myometrial resistance vessels and their alteration in preeclampsia. Hypertens Pregnancy. 1999;18:57-71.
28. Roberts JM. Endothelial dysfunction in preeclampsia. Semin Reprod Endocrinol. 1998;16:5-15.
29. Iwami Y, Masuda H, Asahara T. Endothelial progenitor cells: past, state of the art, and future. J Cell Mol Med. 2004;8:488-497.
30. Redman CW, Sacks GP, Sargent IL. Preeclampsia: an excessive maternal inflammatory response to pregnancy. Am J Obstet Gynecol. 1999;180:499-506.
31. Hubel C, Roberts J. Lipid metabolism and oxidative stress. In: Lindheimer M, Roberts J, Cunningham F, eds. Chesley's Hypertensive Disorders in Pregnancy. Stamford, Conn: Appleton & Lange; 1999:453-486.
32. Hubel CA, Lyall F, Weissfeld L, Gandley RE, Roberts JM. Small low-density lipoproteins and vascular cell adhesion molecule-1 are increased in association with hyperlipidemia in preeclampsia. Metabolism. 1998;47:1281-1288.
33. Kaaja R, Laivuori H, Laakso M, Tikkanen MJ, Ylikorkala O. Evidence of a state of increased insulin resistance in preeclampsia. Metabolism. 1999;48:892-896.
34. Solomon CG, Seely EW. Hypertension in pregnancy - a manifestation of the insulin resistance syndrome? Hypertension. 2001;37:232-239.
35. Lorentzen B, Endresen MJ, Clausen T, Henriksen T. Fasting serum free fatty acids and triglycerides are increased before 20 weeks of gestation in women who later develop preeclampsia. Hypertens Pregnancy. 1994;13:103-109.
36. Powers RW, Bodnar LM, Ness RB, Cooper KM, Galllaher MJ, Frank MP, Daftary AR, Roberts JM. Uric acid concentrations in early pregnancy among preeclamptic women with gestational hyperuricemia at delivery. Am J Obstet Gynecol. In press.
37. Thadhani R, Stampfer MJ, Hunter DJ, Manson JE, Solomon CG, Curhan GC. High body mass index and hypercholesterolemia: risk of hypertensive disorders of pregnancy. Obstet Gynecol. 1999;94:543-550.
38. Kang DH, Finch J, Nakagawa T, Karumanchi SA, Kanellis J, Granger J, Johnson RJ. Uric acid, endothelial dysfunction and pre-eclampsia: searching for a pathogenetic link. J Hypertens. 2004;22:229-235.
39. Mazzali M, Hughes J, Kim YG, Jefferson JA, Kang DH, Gordon KL, Lan HY, Kivlighn S, Johnson RJ. Elevated uric acid increases blood pressure in the rat by a novel crystal-independent mechanism. Hypertension. 2001;38:1101-1106.
40. Roberts JM, Bodnar LM, Lain KY, Hubel CA, Markovic N. Uric acid is as important as proteinuria in identifying fetal risk in women with gestational hypertension. Hypertension. In press.
41. Khong TY, De Wolf F, Robertson WB, Brosens I. Inadequate maternal vascular response to placentation in pregnancies complicated by pre-eclampsia and by small-for-gestational age infants. Br J Obstet Gynaecol. 1986;93:1049-1059.
42. Arias F, Rodriquez L, Rayne SC, Kraus FT. Maternal placental vasculopathy and infection: two distinct subgroups among patients with preterm labor and preterm ruptured membranes. Am J Obstet Gynecol. 1993;168:585-591.
43. Sibai BM, Gordon T, Thorn E, Caritis SN, Klebanoff M, McNellis D, Paul RH. Risk factors for preeclampsia in healthy nulliparous women: a prospective multicenter study. The National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. Am J Obstet Gynecol. 1995;172:642-648.
44. Caritis S, Sibai B, Hauth J, Lindheimer MD, Klebanoff M, Thom E, VanDorsten P, Landon M, Paul R, Miodovnik M, Meis P, Thurnau G. Low-dose aspirin to prevent preeclampsia in women at high risk. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. N Engl J Med. 1998;338:701-705.
45. Powers RW, Evans RW, Ness RB, Crombleholme WR, Roberts JM. Homocysteine and cellular fibronectin are increased in preeclampsia, not transient hypertension of pregnancy. Hypertens Pregnancy. 2001;20:69-77.
46. Laivuori H, Kaaja R, Rutanen EM, Viinikka L, Ylikorkala O. Evidence of high circulating testosterone in women with prior preeclampsia. J Clin Endocrinol Metab. 1998;83:344-347.
47. Eskenazi B, Fenster L, Sidney S. A multivariate analysis of risk factors for preeclampsia. J Am Med Assoc. 1991;266:237-241.
48. Cooper DW, Brennecke SP, Wilton AN. Genetics of pre-eclampsia. Hypertens Pregnancy. 1993;12:1-23.
49. Arngrimsson R, Bjornsson H, Geirsson RT. Analysis of different inheritance patterns in preeclampsia/eclampsia syndrome. Hypertens Pregnancy. 1995;14:27-38.
50. Esplin MS, Fausett MB, Fraser A, Kerber R, Mineau G, Carrillo J, Varner MW. Paternal and maternal components of the predisposition to pre-eclampsia. N Engl J Med. 2001;344:867-872.
51. Roberts JM, Cooper DW. Pathogenesis and genetics of pre-eclampsia. Lancet. 2001;357:53-56.
52. Kosmas IP, Tatsioni A, Ioannidis JP. Association of C677T polymorphism in the methylenetetrahydrofolate reductase gene with hypertension in pregnancy and pre-eclampsia: a meta-analysis. J Hypertens. 2004;22:1655-1662.
53. Arngrimsson R, Sigurardottir S, Frigge ML, Bjarnadottir RI, Jonsson T, Stefansson H, Baldursdottir A, Einarsdottir AS, Palsson B, Snorradottir S, Lachmeijer AM, Nicolae D, Kong A, Bragason BT, Gulcher JR, Geirsson RT, Stefansson K. A genome-wide scan reveals a maternal susceptibility locus for pre-eclampsia on chromosome 2p13. Hum Mol Genet. 1999;8:1799-1805.
54. Moses EK, Lade JA, Guo G, Wilton AN, Grehan M, Freed K, Borg A, Terwilliger JD, North R, Cooper DW, Brennecke SP. A genome scan in families from Australia and New Zealand confirms the presence of a maternal susceptibility locus for pre-eclampsia, on chromosome 2. Am J Hum Genet. 2000;67:1581-1585.
55. Lachmeijer AM, Arngrimsson R, Bastiaans EJ, Frigge ML, Pals G, Sigurdardottir S, Stefansson H, Palsson B, Nicolae D, Kong A, Aarnoudse JG, Gulcher JR, Dekker GA, ten Kate LP, Stefansson K. A genome-wide scan for preeclampsia in the Netherlands. Eur J Hum Genet. 2001;9:758-764.
56. Laivuori H, Lahermo P, Ollikainen V, Widen E, Haiva-Mallinen L, Sundstrom H, Laitinen T, Kaaja R, Ylikorkala O, Kere J. Susceptibility loci for preeclampsia on chromosomes 2p25 and 9p13 in Finnish families. Am J Hum Genet. 2003;72:168-177.
57. van Dijk M, Mulders J, Poutsma A, Konst AA, Lachmeijer AM, Dekker GA, Blankenstein MA, Oudejans CB. Maternal segregation of the Dutch preeclampsia locus at 10q22 with a new member of the winged helix gene family. Nat Genet. 2005;37:514-519.
58. Eskenazi B, Fenster L, Sidney S, Elkin EP. Fetal growth retardation in infants of multiparous and nulliparous women with preeclampsia. Am J Obstet Gynecol. 1993;169:1112-1118.
59. Xiong X, Mayes D, Demianczuk N, Olson DM, Davidge ST, Newburn-Cook C, Saunders LD. Impact of pregnancy-induced hypertension on fetal growth. Am J Obstet Gynecol. 180:207-213, 1999.
60. Chesley LC. Hypertensive Disorders of Pregnancy. New York, NY: Appleton-Century-Crofts; 1978.
61. Redman CWG, Sargent IL. Placental debris, oxidative stress and pre-eclampsia. Placenta. 2000;21(7):597-602.
62. Conrad KP, Benyo DF. Placental cytokines and the pathogenesis of preeclampsia. Am J Reprod Immunol. 1997;37:240-249.
63. Benyo DF, Smarason A, Redman CW, Sims C, Conrad KP. Expression of inflammatory cytokines in placentas from women with preeclampsia. J Clin Endocrinol Metab. 2001;86:2505-2512.
64. Mellembakken JR, Hogasen K, Mollnes TE, Hack CE, Abyholm T, Videm V. Increased systemic activation of neutrophils but not complement in preeclampsia. Obstet Gynecol. 2001;97:371-374.
65. von Dadelszen P, Wilkins T, Redman CWG. Maternal peripheral blood leukocytes in normal and pre-eclamptic pregnancies. Br J Obstet Gynaecol. 1999;106:576-581.
66. Cohen SL, Ho P. Abnormal excretion of oestrogens in complicated pregnancies. Can J Biochem Cell Biol. 1984;62:547-553.
67. Bowyer L, Brown MA, Jones M. Forearm blood flow in pre-eclampsia. BJOG. Int J Obstet Gynaecol. 2003;110:383-391.
68. Murai JT, Muzykanskiy E, Taylor RN. Maternal and fetal modulators of lipid metabolism correlate with the development of preeclampsia. Metabolism. 1997;46:963-967.
69. Dechend R, Muller DN, Wallukat G, Homuth V, Krause M, Dudenhausen J, Luft FC. Activating auto-antibodies against the AT1 receptor in pre-eclampsia. Autoimmun Rev. 2005;4:61-65.
70. Dechend R, Petra G, Shagdarsuren E, Luyten C, Wallukat G, Braesen JH, Mueller D, Pijnenborg R, Dietz R, Luft FC AT1-receptor autoantibodies in a transgenic animal model for preeclampsia. J Am Coll Cardiol. 2005;45:15A-15A.
71. Maynard SE, Min JY, Merchan J, Lim KH, Li J, Mondal S, Libermann TA, Morgan JP, Sellke FW, Stillman IE, Epstein FH, Sukhatme VP, Karumanchi SA. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest. 2003;111:649-658.
72. Levine RJ, Maynard SE, Qian C, Lim KH, England LJ, Yu KF, Schisterman EF, Thadhani R, Sachs BP, Epstein FH, Sibai BM, Sukhatme VP, Karumanchi SA. Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med. 2004;350:672-683.
73. Conner EM, Grisham MB. Inflammation, free radicals, and antioxidants. Nutrition. 1996;12:274-277.
74. Ejima K, Koji T, Tsuruta D, Nanri H, Kashimura M, Ikeda M. Induction of apoptosis in placentas of pregnant mice exposed to lipopolysaccharides possible involvement of Fas/Fas ligand system. Biol Reprod. 2000;62:178-185.
75. Karumanchi SA, Bdolah Y. Hypoxia and sFlt-1 in preeclampsia: the "chicken-and-egg" question. Endocrinology. 2004;145:4835-4837.
76. Stamler FW. Fatal eclamptic disease of pregnant rats fed anti-vitamin E. Stress diet. Am J Pathol. 1959;35:1207-1231.
77. Raijmakers MT, Dechend R, Poston L. Oxidative stress and pre-eclampsia: rationale for antioxidant clinical trials. Hypertension. 2004;44:374-380.
78. Regan CL, Levine R, Baird DD, Ewell MG, Martz KL, Sibai BM, Rokach J, Lawson JA, FitzGerald GA. No evidence for lipid peroxidation in severe preeclampsia. Am J Obstet Gynecol. 2001;185:572-578.
79. Roggensack AM, Zhang Y, Davidge ST. Evidence for peroxynitrite formation in the vasculature of women with preeclampsia. Hypertension. 1999;33:83-89.
80. Zusterzeel PL, Rutten H, Roelofs HM, Peters WH, Steegers EA. Protein carbonyls in decidua and placenta of pre-eclamptic women as markers for oxidative stress. Placenta. 2001;22:213-219.
81. Uotila J, Solakivi T, Jaakkola O, Tuimala R, Lehtimaki T. Antibodies against copper-oxidised and malondialdehyde-modified low density lipoproteins in pre-eclamptic pregnancies. Br J Obstet Gynaecol. 1998;105:1113-1117.
82. Chappell LC, Seed PT, Briley A, Kelly FJ, Hunt BJ, Charnock-Jones DS, Mallet AI, Poston L. A longitudinal study of biochemical variables in women at risk of preeclampsia. Am J Obstet Gynecol. 2002;187:127-136.
83. Gulmezoglu AM, Hofmeyr GJ, Oosthuisen MMJ. Antioxidants in the treatment of severe pre-eclampsia: an explanatory randomised controlled trial. Br J Obstet Gynaecol. 1997;104:689-696.
84. Chappell LC, Seed PT, Briley AL, Kelly FJ, Lee R, Hunt BJ, Parmar K, Bewley SJ, Shennan AH, Steer PJ, Poston L. Effect of antioxidants on the occurrence of pre-eclampsia in women at increased risk: a randomised trial. Lancet. 1999;354:810-816.
85. Beazley D, Ahokas R, Livingston J, Griggs M, Sibai BM. Vitamin C and E supplementation in women at high risk for preeclampsia: a double-blind, placebo-controlled trial. Am J Obstet Gynecol. 2005;192:520-521.
86. Irgens HU, Reisaeter L, Irgens LM, Lie RT. Long term mortality of mothers and fathers after pre-eclampsia: population-based cohort study. BMJ. 2001;323:1213-1217.
87. Chesley LC, Annitto JE, Cosgrove RA. The remote prognosis of eclamptic women: sixth periodic report. Am J Obstet Gynecol. 1976;124:446-459.
88. Funai EF, Paltiel OB, Malaspina D, Friedlander Y, Deutsch L, Harlap S. Risk factors for pre-eclampsia in nulliparous and parous women: the Jerusalem perinatal study. Paediatr Perinat Epidemiol. 2005;19:59-68.